Physician profile
Kyle Lamar Miller
NPI 1073990529
$3,660.71
in general payments reported to CMS, 2019-2025
24 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $149 · 2021: $241 · 2022: $944 · 2023: $711 · 2024: $568 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,667 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,666.93 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $573.21 | 2019-2025 | |
| Amgen INC. | $504.05 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $464.23 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $408.52 | 2019-2024 | Xarelto |
| Irhythm Technologies, INC. | $322.71 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals Lp | $236.84 | 2019-2025 | Enhertu, Farxiga |
| Merck Sharp & Dohme LLC | $208.96 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $153.10 | 2020-2025 | Watchman Flx |
| Kestra Medical Technology Services, INC. | $129.00 | 2023-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.28 | 2019-2024 | Jardiance |
| Pfizer INC. | $78.94 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.49 | 2022 | |
| Philips North America LLC | $63.20 | 2022-2023 | |
| Edwards Lifesciences Corporation | $51.72 | 2019 | |
| Novo Nordisk INC | $46.29 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $43.33 | 2019 | |
| Vital Connect, INC | $38.98 | 2025 | Vitalpatch Rtm |
| Actelion Pharmaceuticals US, INC. | $32.99 | 2021-2022 | |
| Abbott Laboratories | $23.11 | 2023 | Cardiomems |
| Abiomed | $21.81 | 2025 | |
| Lantheus Medical Imaging, INC. | $16.80 | 2019 | |
| Ekos Corporation | $16.38 | 2019 | |
| Chiesi USA, INC. | $14.25 | 2019 | |
| Getinge USA Sales, LLC | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.